Herbs: An alternative approach in Nephroprotection
Suman*
Research Scholar,
Department of Pharmacognosy, Babu Banarasi
Das National Institute of Technology and Management (BBD University), BBD City,
Faizabad Road, Lucknow-
227105 (U.P), India
ABSTRACT:
Kidney stone formation is a worldwide problem, spacing no geographical,
cultural, or racial group. It is an ailment affecting human kind for many
centuries. Epidemiological studies revealed that nephrolithiasis
is more common in man (12%) than in woman (6%) and is more prevalent between
the ages of 20-40 in both the sexes. Estimates of Global burden of disease
indicate that disease of the kidney and urinary tract account for approximately
8, 30,000 deaths and 18,46,700 disability-adjusted life years annually. Calcium
containing stones are the most common comprising about 75% of all urinary
calculi. A number of foods such as spinach, rhubarb, beets, nuts, strawberries
etc. are known to contain high oxalate level, which may combine with calcium to
form crystals that may block urine flow and cause severe pain, while the plants
like Crataeva magna, Tribulus
terrestris, Bergenia ligulata, Costus
spiralis were advantageous in inhibiting stone
formation. According to the American Dietetic Association Nutrition Care
Manual, patient with kidney stones is to restrict dietary oxalate to less than
40-50mg per day. Medicinal plants have been known for millennia and are highly
esteemed all over the world as a rich source of therapeutic agents for the
prevention of various ailments. The present study revealed that approx. 60
plants belonging to different families are extensively used to treat kidney
stones. The review therefore critically evaluates the potential usefulness of
herbal medicine in the management of Nephrolithiasis.
KEYWORDS: Kidney stones,
Management of Kidney stones, Medicinal plants, Nephroprotective
plants, Nephrolithiasis
INTRODUCTION:
A large number of people in this world are suffering from problems due
to urinary stones. There are many areas of high incidence of urinary calculi
which include British Isles, Scandinavian countries, northern Australia,
central Europe, northern India and Pakistan and Mediterranean countries (1).
Urinary calculi have been found in Egyptian mummies dating back to 4000 BC and
in the remains of 1500–1000 BC old North American Indians. Reference to stone
formation is also made in early Sanskrit documents from India between 3000 and
2000 BC (2). Ancient Vedic
literature describes stones as Ashmari (3).
Urinary stones can be considered as fossils representing long-standing
specific conditions of urinary supersaturation in the
collecting system. The risk of calcium oxalate stone formation is generally
discussed on the basis of several parameters (hypercalciuria,
hyperoxaluria, hypocitraturia,
and hypomagnesuria), but the lithogenic
potential has been discussed in terms of urinary calcium oxalate saturation (4).
Urinary oxalate is thought to be derived from 3 sources: 40%~50% is derived
from glycine in the hepatic system, 40%~50% is
derived from the break- down of ascorbic acid in the body, and the remaining
10%~20% is from diet (5).
Hyperoxaluria is a primary risk
factor in calcium oxalate stone formation (5). Calcium containing
stones are the most common comprising about 75% of all urinary calculi, which
may be in the form of pure calcium oxalate (50%) or calcium phosphate (5%) and
a mixture of both (45%) (6). The process of
stone formation depends on urinary volume; concentrations of calcium,
phosphate, oxalate, sodium, and uric acid ions; concentrations of natural
calculi inhibitors (e.g. citrate, magnesium, Tamm-Horsfall
mucoproteins, bikunin); and
urinary pH (2).
Nephrolithiasis:
Nephrolithiasis is a complex process
that results from a succession of several physicochemical events including
super saturation, nucleation, growth, aggregation, and retention within the kidneys(7,8). Lifestyle and dietary
choices implicated in the complex of the metabolic syndrome are important
factors contributing to such developments(9).
Furthermore, nephrolithiasis often indicates the
existence of additional underlying disorders. Regardless of their mineralogy,
two factors are fundamental in kidney stone development: supersaturation
with respect to the forming mineral phase and crystal nucleation (10).
Persons with long-standing history of kidney stones may be more likely to have
had recurrence, thus increasing the likelihood of developing chronic kidney
disease. Hypertension is a well known risk factor for chronic kidney disease.
Chronic kidney disease attributed to interstitial nephritis (or chronic pyelonephritis), has long been known to develop in the
presence of urinary tract infections. Diabetes is the most common cause of
end-stage renal disease in the United States, accounting for 43.2% of all
incident cases in 1998 (11).
When the different types of stone composition are taken into account,
evidence exists that insulin resistance is associated with uric acid stone
disease. The association between insulin resistance and uric acid stone disease
can be explained by a defect in urine acidification, namely to an impaired
L-glutamine system and reduction of Na + K + transport at
the proximal tubule. This change results in very low urine pH which is the main
risk factor for uric acid stone formation. A defect of the Na + K +
and H + transport systems could also be associated with lower
citrate excretion, which is a well known risk factor for calcium stone
formation.
Epidemiologic studies showed that the incidence of nephrolithiasis
increases in patients exhibiting an overweight condition, hypertension, dyslipidaemia and glucose intolerance (12).
Urinary proteins are also believed to play a significant role in the
development of kidney stones, through crystal enlargement and obstruction of
the collecting system, through crystal adherence to renal epithelium, or
through combinations of both these processes. In the early 1950s, Boyce and Sulkin were the first to extract protein from human calcium
stones (13).
Role of Herbs in Nephrolithiasis
The use of botanical medicine is ancient, and plant chemicals are still
the backbone of our pharmacopoeia because more than 50% of drugs used in
Western pharmacopoeia are isolated from herbs or derived from modification of
chemicals first found in plants (14). Due to the high cost and
adverse effects of minimally invasive techniques, and recurrence alternative
treatment modalities with phytotherapeutic agents
have become the mainstay of medical therapy. Recent studies have shown that the
use of phytotherapy along with the watchful waiting
approach can reduce the symptoms of nephrolithiasis
and facilitate stone expulsion (2).
Table 1: Ethnobotanical distribution of plants
used in kidney stone.
|
S.No. |
Country |
Plant |
|
1 |
India |
Sesbania grandiflora
(L.) Aerva lanata (L.) Moringa oleifera Lam. Asparagus racemosus Willd. Rotula aquatica Lour. Cyclea peltata (Lam.) Tribulus terrestris
L. Musa sapientum
L. (banana stem) Mimosa pudica
L. Crataeva nurvala Buch-Ham. |
|
2 |
Japan |
Alisma orientale
(Sam.) Desmodium styracifolium Quercus salicina |
|
3 |
Brazil |
Phyllanthus niruri L. Costus spiralis |
|
4 |
China |
Polyporus umbellatus Atractylodes macrocephala Cinnamomum cassia (L.) |
|
5 |
Iran |
Nigella sativa L. |
Plants with antinephrolithiatic activity
1. Bergenia ciliata
Family: Saxifragaceae
The antiurolithiatic
effect of Bergenia ciliata
(BCE) extract was evaluated for antilithiatic activity on adult
female Wistar rats rendered Urolithiasis
by administration of ethylene glycol. The kidneys
excised from ethylene glycol treated group showed calcification inside the
tubules which causes dilation of the proximal tubules. Co-treatment with BCE
decreased the calcification in different parts of the renal tubules, prevented
damages to the tubules and calyxes and also reduced and prevented the growth of
urinary stones more effectively as compared to cystone
treatment (15).
2.
Bergenia ligulata
Family: Saxifragaceae
The crude aqueous-methanolic extract of Bergenia ligulata rhizome
(BLR) inhibited calcium oxalate crystal aggregation as well as crystal
formation in the metastable solutions and exhibited
antioxidant effect against 1, 1-diphenyl-2-picrylhydrazyl free radical and
lipid peroxidation in the in vitro. BLR caused
diuresis in rats accompanied by a saluretic
effect.
In an animal model of urolithiasis, developed
in male Wistar rats by adding 0.75% ethylene glycol
(EG) in drinking water, BLR (5–10 mg/kg) prevented calcium oxalate crystal
deposition in the renal tubules (16).
3.
Bergenia ligulata, Nigella
sativa and Combination
Family: Saxifragaceae and Ranunculaceae
respectively
Ethanolic extract of Bergenia ligulata and
Nigella sativa and combination were
evaluated for antilithiatic activity on rats rendered
nephrolithiasis by administration of EG. After the
administration of ethanolic extract of Bergenia ligulata and
ethanolic extract of Nigella
sativa and their combination to the group of rats urine analysis shows that
the occurrence of stone was decreased when compared to the kidney stone control
group and the combination (ethanolic extract of Bergenia ligulata and
ethanolic extract of Nigella
sativa) is as
effective as the standard group (Cystine500 mg/kg) (17).
4. Ceiba pentandra
Family: Bombacaceae
Ethylene glycol and ammonium chloride feeding
resulted in hyperoxaluria as well as increased renal
excretion of calcium and phosphate. Supplementation with aqueous and alcohol
extracts of bark of Ceiba pentandra significantly reduced the elevated urinary oxalate
showing a regulatory action on endogenous oxalate synthesis. The increased
deposition of stone forming constituents in the kidneys of calculogenic
rats was significantly lowered by preventive treatment using aqueous and
alcohol extracts. The mechanism underlying this effect is still unknown, but is apparently related to increased diuresis and lowering of urinary concentrations of stone
forming constituents (18).
5.
Coleus aromaticus
Family: Labiatate
Water extract of the leaves of Coleus aromaticus Benth. was tested for its antiurolithiatic
activity against calcium oxalate stones in male albino rats. Calcium oxalate
stones were induced by feeding 3% w/w sodium oxalate along with normal feed. Administration of C.
aromaticus water extract (0.5 g/kg and 1.0 g/kg, once, orally) reduced calcium (23% and
9% respectively) and oxalate (24% and 28% respectively) deposition in the
kidney in calculi producing diet – fed rats (19).
6.
Costus spiralis
Family: Zingiberaceae
The antiurolithiatic activity of the water
extract of Costus spiralis Roscoe
was tested on formation of calculi on implants of calcium oxalate crystals or
zinc disc in the urinary bladder of rats. Oral treatment with the extract of Costus spiralis Roscoe
(0.25 and 0.5 g/kg per day) after 4 weeks surgery reduced the growth of
calculi. The effect, however, was unrelated to increased diuresis
(20).
7.
Crataeva magna
Family: Capparaceae
The ethanol extract (400mg/kg body weight) reduced the elevated level of
serum calcium , urine calcium, urine uric acid level, serum creatinine
and oxalate, urine oxalate and kidney weight significantly with a marked
increase in final body weight and urine volume output when compared with
standard polyherbal drug (Cystone,
5ml/kg body weight) (21).
8.
Dichrostachys cinerea
Family: Mimosaceae
Chronic administration of 0.75% (w/v) aqueous solution of ethylene
glycol to male wistar rats resulted in hyperoxaluria, which is shown by increased elevation of
calcium, phosphate, protein and oxalate. The serum levels of urea, uric acid
and creatinine were remarkably increased in urolithatic rats indicating marked renal damage. However, ethanolic extract of root Dichrostachys
cinerea lower the levels of oxalate as well as
calcium excretion. .It restores phosphate level, thus reducing the risk of
stone formation and hastens the process of dissolving the free form stones and
prevents new stone formation (22).
9.
Grains of Eleusine coracana
Family: Poaceae
Chronic administration of 0.75% (v/v) ethylene glycol aqueous solution
to male albino rats resulted in hyperoxaluria.
Oxalate, calcium and phosphate excretion were grossly increased in
calculi-induced animals. However, supplementation with aqueous and alcohol
extracts of E. coracana grains significantly
lowered the elevated levels of oxalate, calcium and phosphate in urine and
kidney as compared to calculi-induced animal and also lowered the elevated
serum levels of creatinine, uric acid and Blood urea
nitrogen. Treatment with E. coracana grains
extract restored phosphate level, thus reduced the risk of stone formation (23).
10.
Helianthus
annuus
Family: Asteraceae
The effect of aqueous and ethanolic extracts
of Helianthus annuus L. (Sunflower) leaves on
calcium oxalate nephrolithiasis has been studied in
male Albino Wistar rats. Ethylene glycol and ammonium
chloride feeding resulted in hyperoxaluria as well as
increased renal excretion of calcium and phosphorus. Administration of aqueous and
ethanolic extracts of Helianthus annuus Linn. Significantly reduces the elevated level
of calcium oxalate ions which is consider as one of the inhibitor of
crystallization (24).
11. Herpestis monniera
Family: Scrophulariaceae
Methanolic and aqueous extracts
of Herpestis monniera
were found to be effective in reducing deposition of calcium oxalate
in kidney. It also decreased urinary excretion of calcium and oxalate.
Calcium oxalate stones were induced by feeding 0.75% ethylene glycol along with
normal feed (25).
12. Ichnocarpus frutescens
Family: Apocynaceae
Chronic administration of 0.75% (v/v) ethylene glycol aqueous solution
to male Wistar rats resulted in hyperoxaluria.
Supplementation with Ethyl acetate extract of Ichnocarpus frutescens
root (250mg/kg) significantly lowered the elevated levels of oxalate, calcium,
phosphate, BUN (Blood urea nitrogen), Creatinine and
Uric acid (26).
13. Jasminum auriculatum
Family: Oleaceae
Ethylene glycol
feeding resulted in hyperoxaluria as well as
increased renal excretion of calcium and phosphate. Supplementation with
aqueous and alcohol extracts of J. auriculatum flowers
significantly lowered the elevated levels of oxalate, calcium and phosphate in
urine and kidney as compared to cystone-treated
animals (27).
14.
Lantana camara
Family: Verbenaceae
Ethanolic extract of
Lantana
camara
L. (ELC) leaves were evaluated for antiurolithiatic activity
against 0.75% v/v ethylene glycol and 2% w/v ammonium chloride induced calcium
oxalate urolithiasis. Ethylene glycol and ammonium
chloride administration increased the deposition of calcium and oxalate in the
kidneys; also increased urinary excretion of calcium oxalate and creatinine. Treatment with ELC at 0.5 and 1.0 g/kg produced
a significant dose dependent reduction in kidney calcium and oxalate deposition
and dose dependent reduction in urinary calcium, oxalate and creatinine excretion (28).
15.
Lawsonia inermis
Family: Lythraceae
The hydroethanolic extract of Lawsonia inermis L. leaves (HELI) showed
significant antiurolithiatic activity against calcium
oxalate-type stones. Calcium Oxalate crystalluria
could be induced by ethylene glycol and ammonium chloride in rats. When treated
with HELI (200 and 400 mg/kg), showed significant reduction of calcium in
urine. By inhibiting calcium excretion the drug decreases the supersaturation of the urine with respect to Cacium Oxalate and thereby decreased the risk of stone
formation. Apart from urinary calcium excretion, decrease in serum calcium was
evident in urolithiatic rats (29).
16. Melia azadirachta
Family: Meliaceae
The aqueous extract of
Melia azadirachta
L.was
studied against ethylene glycol induced nephrolithiasis
in male albino wistar rats. The aqueous extract of M.
azadirachta reduced urinary calcium, oxalate,
phosphate and elevated urinary magnesium levels and urine volume (30).
17.
Mimusops elengi
Family: Sapotaceae
Hyperoxaluria induced by chronic
administration of 0.75% (v/v) ethylene glycol increased oxalate, calcium, and
phosphate excretion in male albino Wistar rats.
Alcohol extract of M. elengi bark
significantly lowered the elevated
levels of oxalate, calcium and phosphate in urine and kidney, reduced the renal
content of stone forming constituents, restores urinary phosphate level,
thereby reducing the risk of stone formation (31).
18. Momordica charantia
Family- Cucurbitaceae
Antiurolithiatic activity of fruit
extract of M. charantia L. was carried out on
ethylene glycol (0.75% v/v) induced urolithiasis in
rats. Administration of ethylene glycol significantly reduced the body weight,
urine volume and pH of urine as compared to normal group. However, rats treated
with cystone and M. charantia L. showed significant decreased in
body weight, urine volume and pH of urine as compared to control group.
Treatment with Aqueous Extract (200mg/kg, p.o) and
Alcoholic Extract (250mg/kg, p.o) of fruits of M. charantia L. significantly lowered the increased levels
of oxalate, calcium and phosphate in urine,
reduced their retention in kidney and lowered the elevated serum levels
of Blood urea nitrogen, creatinine and uric acid also
(32).
19. Moringa oleifera
Family: Moringaceae
Aqueous extract of bark of Moringa oleifera 400 mg/kg and 800 mg/ were evaluated for
the antiurolithiatic potential in albino rats of Wistar strains. The method used for induction of stones in
this study was zinc disc foreign body insertion technique supplemented
with 1% ethylene glycol in drinking water. Administration of the extract has
resulted in significant reduction in the weight of stones (33).
20.
Musa acuminata and Musa balbisiana
Family: Musaceae
Musa acuminata and Musa balbisiana plant
extract was successful to reduce kidney stone in in-vitro condition.
This is due to the presence of inorganic constituents like magnesium, potassium
and nitrate. Magnesium nitrate and potassium nitrate are the major active
constituents present in the Musa acuminata and
Musa balbisiana stem juice was confirmed by
chemical test and UV spectroscopy. Musa stem juice is effective to dissolve
kidney stone (34).
21.
Pedalium murex
Family: Pedaliaceae
The ethanolic fruit extract of Pedalium murex to ethylene glycol intoxicated rats reverted
the levels of the liver and kidney markers to near normal levels protecting
liver and renal tissues from damage and also prevents the crystal retention in
tissues (35).
22. Pinus eldarica
Family: Pinaceae
Calcium oxalate nephrolithiasis in rats was
induced by administering ethylene glycol (1%v/v). The prophylactic
administration of P. eldarica fruit aqueous
extract (500 mg/kg/day) significantly inhibited the formation of calculi
without diuretic activity. Qualitative analysis of crystalluria
and histopathologic examination showed that the
administered dose of extract prevented stone formation in the kidneys
significantly, by excretion of small particles from the kidney and reducing the
chance of them being retained in the urinary tract. Therefore, the P. eldarica fruit’s extract can maintain calcium oxalate
particles dispersed in the solution and thus, allow them to be eliminated
easily from the kidney (36).
23.
Raphanus sativus
Family: Brassicaceae
The aqueous extract of
Raphanus sativus
showed antilithiatic activity on implants of calcium
oxalate crystals or zinc discs in the urinary bladder of rats. The effect
however is unrelated to increased diuresis or to a change
of the muscarinic receptor affinity of the bladder
smooth musculature to cholinergic ligands (30).
24. Rubia cordifolia
Family: Rubiaceae
Ethylene glycol
feeding resulted in hyperoxaluria, hypocalciuria as well as increased renal excretion of
phosphate. Supplementations with (hydro-alcoholic extract of roots of Rubia cordifolia, HARC) significantly prevented
change in urinary calcium, oxalate and phosphate excretion dose-dependently.
The increased calcium and oxalate levels and number of calcium oxalate crystals
deposits in the kidney tissue of calculogenic rats
were significantly reverted by HARC treatment. The HARC supplementation also
prevents the impairment of renal functions, indicating that the HARC can
protect against ethylene glycol induced urolithiasis
as it reduces and prevents the growth of urinary stones. Therefore, HARC is
helpful to prevent the recurrence of the disease as it showed its effect on
early stages of stone development. The mechanism underlying this effect is
mediated possibly through an antioxidant, nephroprotection
and its effect on the urinary concentration of stone-forming constituents and
risk factors (37).
25.
Salix taxifolia
Family: Salicaceae
The aqueous extract of
the bark of Salix taxifolia
was tested for antilithiatic and diuretic activities.
Urolithiasis was experimentally induced by
implantation of a zinc disc in the urinary bladder of rats. A significant
decrease in the weight of the stones was observed after treatment in animals
with the aqueous extract. This extract caused an increase in the 24h urine
volume (38).
26. Terminalia arjuna
Family: Combretaceae
Preliminary studies on crude aqueous extract showed that Terminalia arjuna is capable of inhibiting formation of
Calcium phosphate (CaP) and Calcium oxalate
monohydrate (COM) crystals. Saponin rich fractions of
other plants like, Herniaria hirsute has also been found to be a
great inhibitor of calcium stone formation not only in vitro but in vivo too. Thus, after conducting a
series of experiments it was observed that butanol
fraction containing high amount of saponins was able
to inhibit initial mineral phase formation of CaP and
growth of COM crystals along with the crude aqueous extract of Terminalia arjuna (39).
27.
Tinospora cordifolia
Family: Menispermaceae
Ethanolic extract of T. cordifolia stem indicate the presence of alkaloids,
glycosides, carbohydrates, phenolic compounds and
tannins. The extract of plants inhibited the crystallization of Calcium oxalate
in solution, thereby reduced supersaturation and the
size of the particles. T. cordifolia also has
claimed to have diuretic effect and diuretic effects may also reduce stone
development (40).
Table 2: Some other
medicinal plants with their mode of action
|
S.No. |
Plant name |
Family |
Mechanism
of Action |
|
1 |
Achyranthes indica |
Amaranthaceae |
Inhibitory effect on crystal nucleation and
aggregation, diuretic (44). |
|
3 |
Aerva lanata |
Amaranthaceae |
Reduced the activities of Glycolic acid oxidase and lactate dehydrogenase
and oxalate levels to near normal control (45). |
|
4 |
Ammi visnaga |
Apiaceae |
Potent diuretic, khellin
and visnagin prevent renal epithelial cell damage
caused by oxalate and COM (30). |
|
5 |
Carica
papaya |
Caricaceae |
Decreases the level of calcium phosphorus
and oxalate in renal tissue and urine (46). |
|
6 |
Dolichos biflorus |
Fabaceae |
Decreases calcium phosphate precipitation (30). |
|
7 |
Herniaria hirsute |
Caryophyllaceae |
Decrease crystal size and increase COD,
diuretic (30). |
|
8 |
Hygrophila spinosa |
Acanthaceae |
Lowered the level of calcium, phosphate, oxalate and protein excretion in urine (47). |
|
9 |
Nigella sativa |
Ranunculaceae |
Decreases urine concentration of oxalate
and creatinine (48). |
|
10 |
Paronychia argentea |
Illecebraceae |
Reduced and prevented the growth of urinary
stones (8). |
|
11 |
Pergularia daemia |
Asclepediaceae |
Lowering of urinary concentration of stone
forming constituents, diuretic (49). |
|
12 |
Phyla nodiflora |
Verbenaceae |
Reduce the supersaturation
of urine with calculogenic ions, diuretic,
antioxidant and restored the level of catalase and
GSH (50). |
|
13 |
Quercus salicina |
Fagaceae |
Reduction in oxalate induced renal
epithelial cell injury (30). |
|
14 |
Rotula
aquatic |
Boraginaceae |
Lowers the level of oxalate and calcium
excretion, restored phosphate level (51). |
|
15 |
Smilax china |
Liliaceae |
Reduction of uric acid production by
inhibiting Xanthine oxidase
activity and enhancement of urate excretion by
increasing urinary volume (52). |
|
16 |
Trachyspermum ammi |
Umbelliferae |
Maintain renal functioning; Reduce renal
injury and decrease crystal excretion in urine and retention in renal tissues
(53). |
28.
Tribulus terrestris
Family: Zygophyllaceae
T. terrestris
extract contains high concentration of magnesium which
inhibits calcium oxalate and calcium phosphate stone formation by inhibiting
the formation and aggregation of calcium with oxalate and phosphate to form
crystals in the urinary tracts. After the administration of T.terrestris
extract, the levels of uric acid, oxalate, calcium, proteins and glycosaminoglycans in serum and urine changed significantly,
while the citrate, inorganic phosphate and urine volume were not
significantly affected. Therefore the T. terrestris
extract may be useful in the treatment of urolithiasis
(41).
29.
Tridax procumbens
Family: Asteraceae
Ethanolic extract of T. procumbens (ETP) was evaluated against
0.75% v/v ethylene glycol and 2% w/v ammonium chloride induced calcium oxalate urolithiasis and hyperoxaluria
induced oxidative stress in male albino rats. On administration, the dose
dependent reduction in urinary and renal calcium and oxalate compared to the
control rats indicates Tridax procumbens
prevented urinary supersaturation of
Calcium Oxalate. The antiurolithiatic effect of ETP
may be attributed to its saponin principles as the
extract was found to contain saponins in preliminary phytochemical screening and earlier researchers isolated, lupane type pentacyclic triterpene saponin derivative
from T. procumbens. The effect of ETP in reducing calcium and oxalate excretion and
deposition may be due to its flavonoid principles as
earlier researchers isolated a flavonoid (procumbenetin) from T. procumbens
(42).
30.
Cystone
This formulation has been approved by regulatory authorities in India
and showed beneficial effects revealed by the improvement of various clinical
symptoms, increased stone expulsion rate and the time required for expulsion as
well as urine microscopy (WBC and RBC). The principal herbs of this Ayurvedic tablets include extracts of Didymocarpus
pedicellata, Saxifraga
lingulata, Rubia
cordifolia, Cyperus
scariosus, Achyranthes
aspera, Onosma
bracteatum, and Vernonia
cineria.
The beneficial actions of Ayurvedic
formulation (Cystone) could be due to the complex
spectrum of actions including antiinflammatory,
antimicrobial, diuretic, antispasmodic, litholytic,
and anticalcifying activities of its ingredients (2).
31.
Jawarish Zarooni Sada
Jawarish Zarooni Sada is a reputed polyherbal
preparation containing 15 ingredients like Cucumis
melo Linn; Apium
graveolens; Daucus
carota; Trachyspermum
ami Sprague; Feniculum
vulgare Mill; Syzygium
aromaticum Merr and
Perry; Piper nigrum Linn.; Cinnamomum
zeylanicum Blume. etc. It is a standardized pharmacopoeal
preparation that has been described in Unani
literature, to be diuretic, tonic to kidney and nephroprotective,
useful in burning micturation, nephritis, and nephrotic syndrome like conditions (43).
CONCLUSION:
Medicinal plants are used from centuries due
to its safety, efficacy, cultural acceptability and lesser side effects as
compared to synthetic drugs. Hence, to increase the acceptability and awareness
among the people, there is an urgent need to develop trust and faith towards
the safer indigenous system by establishing its validity in treatment for
various diseases. Health care systems are going to become more and more
expensive, therefore we have to introduce herbal medicine systems in our health
care. The
reviewed studies show that some possible
mechanisms of action of plant extracts include an increased excretion of
urinary citrate, decreased excretion of urinary calcium and oxalate or could be
attributable to diuretic, antioxidant or antibacterial effects. The need of the
hour is to develop an effective, safe and standardized herbal preparation for
the management of nephrolithiasis. Systematic
research needs to be undertaken, in an attempt to explore botanicals as
alternative and/or complementary medicines for the treatment of nephrolithiasis.
REFERENCES:
1.
Beghalia M, Ghalem S, Allali
H, et al. Inhibition of calcium oxalate monohydrate crystal growth using Algerian
medicinal plants. Journal of
Medicinal Plants. 2; 2008: 066-070.
2.
Sekar Kumaran MZ and Patki PS. Evaluation of an Ayurvedic
formulation (Cystone), in urolithiasis:
A double blind, placebo-controlled study. European
Journal of Integrative Medicine. 3; 2011: 23–28.
3.
Prachi, Chauhan N, Kumar D, et al. Medicinal plants of Muzaffarnagar district used in treatment of urinary tract
and kidney stones. Indian Journal of
Traditional Knowledge. 8; 2009: 191-195.
4.
Ogawa Y, Yonou H, Hokama
S, et al. Urinary Saturation and Risk Factors For Calcium Oxalate Stone Disease
Based on Spot and 24-Hour Urine Specimens. Frontiers in Bioscience. 8;
2003: 167-176.
5.
Jeng-Yu Tsai, Jong-Khing Huang,
Tony T. Wu, et al. Comparison of Oxalate Content in Foods and
Beverages in Taiwan. JTUA.
16(3); 2005: 93-98.
6.
Bijarnia RK, Kaur T, Singla SK, et al. Non-surgical management therapies for kidney
stones. J
Pharmceutical Education and Research. 1(1); 2010: 21-25.
7.
Butterweck V and Khan SR. Herbal Medicines in the Management of Urolithiasis: Alternative or Complementary. Planta Med. 75; 2009: 1095–1103.
8.
Bouanani S, Henchiri C, Migianu-Griffoni E, et
al. Pharmacological and toxicological effects of Paronychia
argentea in experimental calcium oxalate nephrolithiasis in rats. Journal of Ethnopharmacology. 129; 2010:
38–45.
9.
Knoll T. Epidemiology, Pathogenesis, and Pathophysiology of Urolithiasis. European Urology. 9; 2010: 802 –806.
10.
Aloisi G. An alternative origin for nanobacteria
in kidney stones. Bioscience Hypotheses.
1; 2008: 138-141.
11. Vupputuri S, Soucie JM, McClellan W, et al. History of Kidney Stones as a Possible Risk Factor for Chronic Kidney
Disease. AEP. 14(3); 2004:
222–228.
12.
Cupisti A, Meola M, Alessandro
CD, et al. Insulin resistance and low urinary citrate
excretion in calcium stone formers. Biomedicine
and Pharmacotherapy. 61; 2007: 86-90.
13.
Canales B K, Anderson L, Higgins L, et al. Proteome of Human Calcium Kidney
Stones. Urology Journal. 76
(4); 2010: 13-20.
14.
Bagnis CI, Deray G, Baumelo A, et al.
Herbs and the Kidney. American
Journal of Kidney Diseases.
44(1); 2004: 1-11.
15.
Saha and Verma RJ. Bergenia ciliata extract prevents Ethylene Glycol induced histopathological changes in the Kidney. Acta Poloniae Pharmaceutica-Drug Research. 68(5); 2011: 711- 715.
16.
Bashir S and Gilani AH. Antiurolithic effect of Bergenia
ligulata rhizome: An explanation of the
underlying mechanisms. Journal of Ethnopharmacology. 122; 2009: 106-116.
17. Harsoliya MS, Pathan JK, Khan N, et al. Effect of Ethanolic extracts of Bergenia Ligulata, Nigella Sativa and combination on Calcium Oxalate Urolithiasis in Rats. International Journal of Drug
Formulation and Research. 2; 2011: 268-280.
18.
Choubey Ankur, Choubey Aadarsh, Jain P, et al. Assessment of Ceiba
pentandra on Calcium Oxalate Urolithiasis
in Rats. Scholars Research Library Der Pharma Chemica. 2; 2010:
144-156.
19.
Ghosh RB, Sur TK, Maity LN, et al. Antiurolithiatic
activity of Coleus aromaticus
Benth. in Rats. Ancient Science of
Life. XX (1and2); 2000: 1-4.
20.
, , et alEvaluation of the antiurolithiatic
activity of the extract of Costus spiralis Roscoe. in rats. Journal of Ethnopharmacology.
66; 1999: 193-198.
21.
Mekap SK, Mishra S, Sahoo S, et al. Antiurolithiatic activity of Crataeva magna Lour. Bark. Indian Journal
of Natural Products and Resources. 2; 2011: 28-33.
22.
Jayakumari S, Anbu J and Ravichandran V. Antiurolithiatic
activity of Dichrostachys cinerea (L.) Wight and Arn
root extract. Journal of Pharmacy
Research. 4; 2011:
1206-1208.
23.
Bahuguna YM, Rawat MSM, Juyall V, et al.
Antilithiatic effect of grains of Eleusine Coracana. Saudi
Pharmaceutical Journal. 17; 2009:
182-188.
24.
Khan NI, Shinge JS and Naikwade
NS. Antilithiatic effect of Helianthus Annuus Linn. Leaf Extract in Ethylene Glycol and ammonium
chloride induced Nephrolithiasis. International
Journal of Pharmacy and Pharmaceutical Sciences. 2; 2010: 180-184.
25.
Shri Vijaya Kirubha T, Senthamarai R, Vasuki K, et al. Antiurolithiatic activity Of Herpestis
Monniera aerial parts in rats. Advanced Pharmacology Toxicology. 12; 2011: 25-29.
27.
Bahuguna Y, Rawat MM, Juyal V, et al. Antilithiatic effect of flowers of Jasminum
Auriculatum Vahl. International Journal of Green Pharmacy.
3; 2009: 155-158.
28.
Mayee R and Thosar A. Evaluation of Lantana camara
Linn. (Verbenaceae)
for Antiurolithiatic and Antioxidant Activities in
Rats. International Journal of Pharmaceutical
Clinical Research. 3; 2011:10-14.
29.
Kore KJ, Shete RV, Jadhav PJ, et al.
Antiurolithiatic effects of Hydroalcoholic
extract of Lawsonia
Inermis L.
Leaves. International
Journal of Universal Pharmacy and Life Sciences. 1; 2011: 81-95.
30.
Yadav RD, Jain SK, Alok
S, et al. Herbal Plants used in the treatment of Urolithiasis:
A Review. International Journal of Pharmaceutical Sciences and Research.
2; 2011: 1412-1420.
31.
Ashok P, Basavaraj CK and Vishwanathswamy
AHM. Antiurolithiatic and antioxidant activity of Mimusops elengi on
ethylene glycol-induced urolithiasis in rats. Indian Journal
of Pharmacology.
42; 2010: 380-383.
32.
Shah BN, Raiyani KD and Modi
DC. Antiurolithiatic activity studies of Momordica charantia
Linn. Fruits. International Journal
of Pharmacy Research and Technology. 1; 2011: 06-11.
33. Jameel Fahad,
Vijayalakshmi, Kumar MCS, et al. Antiurolithiatic activity of
aqueous extract of bark of Moringa oleifera (lam.) in rats. Health. 2; 2010:
352-355.
34.
Prasobh GR and Revikumar KG. Use
of Musa AAB in Kidney Stone Treatment and other Diseases. Asian Journal of
Pharmaceutical and Clinical Research. 4;
2011: 117-118.
35.
Ananta Teepa KS, Kokilavani
R, Balakrishnan A, et al. Effect of Ethanolic fruit extract
of Pedalium murex L. in ethylene glycol induced Urolithiasis in male Wistar
albino rats. Ancient Science of Life.
29; 2010: 29-34.
36.
Hosseinzadeh H, Khooei AR, Khashayarmanesh Z, et
al. Antiurolithiatic Activity of Pinus Eldarica Medw. Fruits Aqueous Extract in Rats. Urology Journal. 7; 2010: 232-237.
39.
Chaudhary A, Singla SK and Tandon C. In vitro Evaluation of Terminalia arjuna on Calcium Phosphate
and Calcium Oxalate Crystallization. Indian Journal of
Pharmaceutical Sciences. 72; 2010:
340-345.
40.
Kumar GP, Mittal Arun and Kumar Rishi. Evaluation of Tinospora
cordifolia for Antiurolithiatic
Potential. Journal of Pharmaceutical and Biomedical Sciences. 9; 2011: 1-5.
41.
Arasaratnam V, Balakumar S, Senthuran A, et al.
A study of Tribulus terrestris
extract on risk factors for urinary stone in normal subjects and urolithic patients. Journal of National Science Foundation of Sri Lanka. 38; 2010: 187-191.
42.
Sailaja B, Bharathi K and Prasad
KVSRG. Protective Effect of Tridax Procumbens L. on Calcium Oxalate Urolithiasis
and Oxidative Stress. PHARMANEST - An International Journal of Advances in
Pharmaceutical Sciences. 2; 2011: 9-14.
43.
Afzal M, Khan
NA, Ghufran A, et
al. Diuretic and nephroprotective effect of Jawarish Zarooni Sada—a polyherbal unani formulation. Journal of Ethnopharmacology.
91; 2004: 219–223.
44.
Pareta SK, Patra
KC and Harwansh R. In-vitro calcium oxalate
crystallization inhibition by Achyranthes indica Linn. hydroalcoholic
extract: An Approach to Antilithiasis. International
Journal of Pharmaceutical and Biomedical Sciences. 2; 2011: 432-437.
45.
Soundararajan P, Mahesh R, Ramesh T, et al. Effest of Aerva lanata on calcium oxalate urolithiasis
in rats. Indian Journal of Experimental
Biology. 44; 2006: 981-986.
46.
Nayeem K, Gupta
D, Nayana H, et
al. Antiurolithiatic potential of the fruit
extracts of Carica papaya on ethylene glycol induced urolithiatic rats. Journal of Pharmacy Research. 3;
2010: 2772-2775.
47. Sathish R, Natarajan
K and Nikhad MM. Effect of Hygrophila
Spinosa T. Anders on Ethylene Glycol induced Urolithiasis in Rats. Asian Journal of Pharmaceutical and Clinical
Research. 3; 2010: 61-63.
49. Vyas
BA, Vyas RB, Joshi SV, et al. Antiurolithiatic Activity of Whole-Plant Hydroalcoholic
Extract of Pergularia daemia
in Rats. Journal of Young Pharmacist. 3; 2011:
36-40.
50.
Dodoala S, Ranjanayakulu
D, Koganti B, et
al. Effect of ethanolic extract of Phyla nodiflora
Linn. Greene against calculi producing diet induced urolithiasis.
Indian journal of natural Products and
Resources. 1; 2010: 314-321.
51.
Gilhotra UK and
Christina AJM. Effect of Rotula aquatica Lour.
on ethylene-glycol induced urolithiasis
in rats. International Journal of Drug
Development and Research. 3; 2011: 273-280.
52.
Lvyi Chen, Huafeng Yin, Zhou Lan, et al. Anti-hyperuricemic and nephroprotective
effects of Smilax china L. Journal of Ethnopharmacology. 135; 2011: 399–405.
53.
Kaur T, Bijarnia RK, Singla SK, et al.
In vivo efficacy of Trachyspermum ammi anticalcifying protein in urolithiatic
rat model. Journal of Ethnopharmacology. 126; 2009: 459–462.
Received on 28.10.2012
Modified on 12.11.2012
Accepted on 19.11.2012
© A&V Publication
all right reserved
Research
Journal of Pharmacognosy and Phytochemistry. 5(1): January–February
2013, 15-21